The market for chimeric antigen receptor T cell therapies

Yip, Amy, Webster, Rachel M.·2018·Nature Reviews Drug Discovery
DOI 10.1038/nrd.2017.266

Cited by (137)

Items 101–137 of 137

  1. Synthetic Receptor-Based Targeting Strategies to Improve Tumor Drug Delivery
    Susheel Kumar Nethi, Shubhmita Bhatnagar, Swayam Prabha · 2021 · AAPS PharmSciTech
  2. Multi-Sensitive Au NCs/5-FU@Carr-LA Composite Hydrogels for Targeted Multimodal Anti-Tumor Therapy
    Chunxia Qi, Ang Li, Baoming Wu, Peisan Wang · 2024 · Molecules
  3. Decentralized Point-of-Care Manufacturing of CD19 Chimeric Antigen Receptor T Cells in Mexico
    Rosario Salazar‐Riojas, Dalila Marisol Alvarado‐Navarro, Yair Omar Chávez-Estrada, Ana Karen Hernández-Navarro, Martha Berenice Ake-Uc, Nidia Karina Moncada-Saucedo, José Carlos Jaime‐Pérez, Sofía I. Quezada-Ramírez, Anna Cecilia Rodríguez-Zúñiga, David Gómez‐Almaguer et al. · 2025 · JCO Global Oncology
  4. Strategies to overcome the side effects of chimeric antigen receptor T cell therapy
    Mohadeseh Mirzaee Godarzee, Bashdar Mahmud Hussen, Ehsan Razmara, Benyamin Hakak‐Zargar, Fatemeh Mohajerani, Hamed Dabiri, Mohammed Fatih Rasul, Mohammad H. Ghazimoradi, Sadegh Babashah, Majid Sadeghizadeh · 2022 · Annals of the New York Academy of Sciences
  5. Conjugating Micropatches to Living Cells Through Membrane Intercalation
    Miao Yu, Hailing Liu, Wenhao Cheng, Yang Liu, Sundol Kim, Xuegang Yuan, Aubrey E. Kusi-Appiah, Steven Lenhert, Teng Ma, Yi Ren et al. · 2020 · ACS Applied Materials & Interfaces
  6. Design and preclinical testing of an anti‐CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia
    Adrian Bogdan Țigu, Catalin Sorin Constantinescu, Patric Teodorescu, Dávid Kegyes, Raluca Andrada Munteanu, Richard Feder, Mareike Peters, Ioana-Ecaterina Pralea, Cristina Adela Iuga, Diana Cenariu et al. · 2023 · Journal of Cellular and Molecular Medicine
  7. Engineering precision therapies: lessons and motivations from the clinic
    Mingqi Xie, Mirta Viviani, Martin Fussenegger · 2020 · Synthetic Biology
  8. Industrializing CAR-T cell therapy: impact of automation on cost and space efficiency of manufacturing facilities
    Anna Louisa Weltin, Ysanne de Graaf, Amir Goudarzi, MJ Müller, Laura Herbst, Bastian Nießing, Hubertus JM Vrijhoef, Robert Heinrich Schmitt · 2026 · Frontiers in Bioengineering and Biotechnology
  9. Advancement in “Off-the-Shelf” CAR T-Cell Therapy for Cancer Immunotherapy
    Mohsen Sheykhhasan, Anita Silas La’ah, Amirhossein Ahmadieh-Yazdi, Piao Yang, Hamid Tanzadehpanah, Hanie Mahaki, Hamed Manoochehri, Naresh Poondla, Naser Kalhor, Sharafaldin Al-Musawi · 2024 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  10. Fine-tuning signal strength in CD5 CAR-NK cells for targeted T cell cancer therapy
    Seona Jo, Yu Bin Lee, Seok‐min Kim, Soo Yun Lee, Myeongjin Choi, Mi-lang Kyun, Seo Yule Jeong, Sunyoung Lee, Ji Hyun Kim, Yoonji Kim et al. · 2025 · Frontiers in Immunology
  11. Titrating chimeric antigen receptors on CAR T cells enabled by a microfluidic-based dosage-controlled intracellular mRNA delivery platform
    Yu‐Hsi Chen, Mahnoor Mirza, Ruoyu Jiang, Abraham Phillip Lee · 2024 · Biomicrofluidics
  12. Multimodal Key Anti-Oncolytic Therapeutics Are Effective In Cancer Treatment?
    Luyi Ye, Meng Gao, Yue Chen, Yuting Zhu, Jilong Wang, Z W Wang · 2025 · International Journal of Nanomedicine
  13. TANK shapes an immunosuppressive microenvironment and predicts prognosis and therapeutic response in glioma
    Shasha Li, Youwei Guo, Huijuan Hu, Na Gao, Xuejun Yan, Quanwei Zhou, Hui Liu · 2023 · Frontiers in Immunology
  14. Novel xeno-free and serum-free culturing condition to improve piggyBac transposon-based CD19 chimeric antigen receptor T-cell production and characteristics
    Mulita Sanyanusin, Suparat Tudsamran, Rattapoom Thaiwong, Supannikar Tawinwung, Nobuhiro Nishio, Yoshiyuki Takahashi, Nattiya Hirankarn, Koramit Suppipat · 2022 · Cytotherapy
  15. The European Innovation Council supports innovative portfolios in health biotech
    Iordanis I. Arzimanoglou · 2024 · Nature Biotechnology
  16. High-Throughput Direct Cell Counting Method for Immuno-Oncology Functional Assays Using Image Cytometry
    Leo Li‐Ying Chan · 2020 · Methods in pharmacology and toxicology
  17. Revolutionizing the treatment of cancer using CAR T Cells and Bispecific Antibodies
    Saritha Medapati, Haripriya B.V.S.L, Priyanka Jyothi Dummari, Vinodkumar Mugada, Rooth Vasantha Medapati, Srinivasa Rao Yarguntla · 2024 · Palestinian medical and pharmaceutical journal/Palestinian medical & pharmaceutical journal
  18. The Most Logical Approach to Improve CAR T Cell Therapy
    Seung-Hee Lee, Wilson W. Wong · 2020 · Cell Systems
  19. A Comprehensive Review of Systemic Targeted Therapies in Cancer Treatment
    Amit Kumar Sharma, Hemant R. Jadhav, Anubhav Rai, Naga Rajiv Lakkaniga, Harish Chinna Konda Chandramoorthy, Hossam Mohammed Kamli, Mohammad Yahya Alshahrani, Prasanna Rajagopalan · 2023 · Current Cancer Therapy Reviews
  20. How to Test Human CAR T Cells in Solid Tumors, the Next Frontier of CAR T Cell Therapy
    Russell W Cochrane, Andrew Fiorentino, Eva Allen, Rob A. Robino, Jaime Quiroga, Leonardo M. R. Ferreira · 2023 · Methods in molecular biology
  21. Construction of anti-HER2 affibody-directed CAR-NK and its synergistic effects with doxorubicin-loaded nanodrug against HER2-positive breast cancer
    Xuesong He, Zhaoyuan Liang, Qing Liu, Xiaofei Zhang, Hao Liang, 贾润清, Wang Sheng · 2026 · Frontiers in Immunology
  22. Overcoming five main challenges to targeting hematologic malignancies
    Megha Thakkar, Patrick J. Hanley, Alexey Bersenev, David Steffin · 2026 · Cytotherapy
  23. Advances and prospects in cell therapy for cancer: explorations from T cells to stem cells
    Guisha Zi, Li Zhang, Ling Zhou, Xiansheng Liu, Lingling Wang, Runxuan Zhou, Pengdou Zheng, Jia Wei, Xiaoping Chen, Shuang Wei · 2026 · Signal Transduction and Targeted Therapy
  24. Precision medicine as a promising tool to empower research in healthcare industry
    Sachdeva Mayank, Suhani Sinha · 2018 · GSC Biological and Pharmaceutical Sciences
  25. Vaccines as Immunotherapy
    Pratik Ogale, Vandana S. Nikam, Manish Gautam, Sunil Gairola, S. S. Jadhav · 2020 · Springer eBooks
  26. Single-Cell Technologies for Cancer Therapy
    Geng‐Ming Hu, Victor Daniel Lee, Hung‐Yu Lin, Pu-Wei Mao, Hsin‐Yi Liu, Jih-Hou Peh, Chih‐Wei Chen · 2021 · Springer eBooks
  27. Titering of Chimeric Antigen Receptors on CAR T Cells enabled by a Microfluidic-based Dosage-Controlled Intracellular mRNA Delivery Platform
    Yu-Hsi Chen, Ruoyu Jiang, Abraham Phillip Lee · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  28. T Cell Engineering and the Rise of CAR-T Cell Therapies
    Benjamin I. Philipson, Michael C. Milone · 2020 · Elsevier eBooks
  29. Single-Cell Technologies for Cancer Therapy
    Geng‐Ming Hu, Victor Daniel Lee, Hung‐Yu Lin, Pu-Wei Mao, Hsin‐Yi Liu, Jih-Hou Peh, Chih‐Wei Chen · 2019 · Springer eBooks
  30. Designed synthesis of silica based nanocarriers for mRNA delivery
    Yue Wang · 2020 · The University of Queensland
  31. CAR (Chimeric Antigen Receptor) T-Cell Therapy: Immuno-Oncology, Immunomodulation, and Immunotherapy in Cancer
    Vikas Kumar Maurya · 2021 · Translational Biomedicine
  32. Effects of the COVID-19 pandemic on publication landscape in chimeric antigen receptor-modified immune cell research
    Ahmet Yilmaz, Jianhua Yu · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Quantitative Approach to Supramolecular Assembly Engineering for Isolating and Activating Antigen-Specific T Cells
    Mason R. Smith · 2018 · Deep Blue (University of Michigan)
  34. Data from Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy
    Mohamed Abou‐El‐Enein, Magdi Elsallab, Steven A. Feldman, Andrew D. Fesnak, Helen Elisabeth Heslop, Peter W Marks, Brian G. Till, Gerhard Bauer, Barbara Savoldo · 2023
  35. Effects of different serum supplements on PiggyBac CD19 Chimeric Antigen Receptor T cells
    Mulita Sanyanusin · 2022
  36. CAR-T Cells – Main Steps for Obtaining a Proper “Live Drug” Adoptive Therapy
    Monica Teodora Neagu, Carolina Constantin · 2024 · South East European Journal of Immunology
  37. Engineering Nonpathogenic Bacteria for Synergistic Tumor-Targeted Protein Degradation and Immunotherapy by Checkpoint-Inhibiting Nanobodies
    Xinping Hu, Yu Chen, Meiyuan Jin, Qirong Xiong, Jinghua Ren, Hongwei Duan · 2026 · Journal of the American Chemical Society